Together, these results demonstrate that silencing of matriptase expression, or inhibition of matriptase catalytic activity, leads to decreased pro-HGF activation and subsequent c-Met signaling pathway activation, ultimately causing impairment of the proliferative and invasive response in IBC cells. The gene discussed is ST14; the disease is inflammatory breast carcinoma.